Articles

Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy

Department of Internal Medicine III, University Hospital Ulm, Germany
Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany
Department of Internal Medicine III, University Hospital Ulm, Germany
Department of Oncology and Hematology, Klinikum Braunschweig, Germany;Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Germany
Department of Internal Medicine III, University Hospital Ulm, Germany
Department of Internal Medicine III, University Hospital Ulm, Germany
Department of Oncology and Hematology, Klinikum Oldenburg, Germany
Department of Internal Medicine II, University Hospital Schleswig-Holstein Campus Kiel, Germany
Department of Internal Medicine III, CIO, University Hospital of Bonn, Germany
Department of Hematology/Oncology, University-hospital Giessen, Germany
Department of Internal Medicine III, Technical University of Munich, Germany
Department of Hematology/Oncology, Hanuschkrankenhaus, Wien, Austria
Department of Medical Oncology and Hematology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
Department of Hematology/Oncology, Asklepios Klinik Altona, Hamburg, Germany
Department of Internal Medicine II, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Department of Hematology/Oncology, Krankenhaus der Barmherzigen Brüder, Trier, Germany
Department of Hematology and Oncology, Georg-August-University Hospital of Göttingen, Germany
Department of Hematology/Oncology, Caritas-Krankenhaus, Lebach, Germany
Department of Medicine III, Johannes Gutenberg-University Mainz, Germany
Department of Hematology/Oncology, Caritas-Krankenhaus, Saarbrücken, Germany
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Germany
Department of Internal Medicine III, University Hospital Ulm, Germany
Department of Internal Medicine III, University Hospital Ulm, Germany
Vol. 101 No. 7 (2016): July, 2016 https://doi.org/10.3324/haematol.2015.141622